Skip to content
healthcare.dev
Get a free key

Allergena Zone 9 Trees, Weeds and Grasses

NDC 62713-989, Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Phytolacca decandra, Trigonella foenum-graecum, Zone 9 Tree, Zone 9 Weed, Zone 9 Grass, liquid, from Meditrend, Inc. DBA Progena Professional Formulations.

Product NDC
62713-989
Status
Listed
Labeler
Meditrend, Inc. DBA Progena Professional Formulations
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62713-989 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ECHINACEA, UNSPECIFIED3 [hp_X]/mL
  • BAPTISIA TINCTORIA ROOT3 [hp_X]/mL
  • GOLDENSEAL3 [hp_X]/mL
  • MYRRH3 [hp_X]/mL
  • PHYTOLACCA AMERICANA ROOT3 [hp_X]/mL
  • FENUGREEK LEAF3 [hp_X]/mL
  • ACACIA POLLEN30 [hp_X]/mL
  • ALNUS INCANA SUBSP. RUGOSA POLLEN30 [hp_X]/mL
  • FRAXINUS VELUTINA POLLEN30 [hp_X]/mL
  • POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN30 [hp_X]/mL
  • ULMUS CRASSIFOLIA POLLEN30 [hp_X]/mL
  • ULMUS PUMILA POLLEN30 [hp_X]/mL
  • EUCALYPTUS GLOBULUS POLLEN30 [hp_X]/mL
  • JUNIPERUS SCOPULORUM POLLEN30 [hp_X]/mL
  • LIGUSTRUM VULGARE POLLEN30 [hp_X]/mL
  • PROSOPIS JULIFLORA POLLEN30 [hp_X]/mL
  • MORUS ALBA POLLEN30 [hp_X]/mL
  • QUERCUS AGRIFOLIA POLLEN30 [hp_X]/mL
  • OLEA EUROPAEA POLLEN30 [hp_X]/mL
  • PHOENIX DACTYLIFERA POLLEN30 [hp_X]/mL
  • PINUS STROBUS POLLEN30 [hp_X]/mL
  • LIQUIDAMBAR STYRACIFLUA POLLEN30 [hp_X]/mL
  • PLATANUS OCCIDENTALIS POLLEN30 [hp_X]/mL
  • AILANTHUS ALTISSIMA POLLEN30 [hp_X]/mL
  • JUGLANS NIGRA POLLEN30 [hp_X]/mL
  • SALIX NIGRA POLLEN30 [hp_X]/mL
  • ATRIPLEX CANESCENS POLLEN30 [hp_X]/mL
  • AMARANTHUS PALMERI POLLEN30 [hp_X]/mL
  • RUMEX CRISPUS POLLEN30 [hp_X]/mL
  • CHENOPODIUM ALBUM POLLEN30 [hp_X]/mL
  • AMARANTHUS RETROFLEXUS POLLEN30 [hp_X]/mL
  • PLANTAGO LANCEOLATA POLLEN30 [hp_X]/mL
  • AMBROSIA ACANTHICARPA POLLEN30 [hp_X]/mL
  • AMBROSIA PSILOSTACHYA POLLEN30 [hp_X]/mL
  • SALSOLA TRAGUS POLLEN30 [hp_X]/mL
  • CYNODON DACTYLON POLLEN30 [hp_X]/mL
  • BROMUS INERMIS POLLEN30 [hp_X]/mL
  • BROMUS SECALINUS POLLEN30 [hp_X]/mL
  • SORGHUM HALEPENSE POLLEN30 [hp_X]/mL
  • POA PRATENSIS POLLEN30 [hp_X]/mL
  • FESTUCA PRATENSIS POLLEN30 [hp_X]/mL
  • DACTYLIS GLOMERATA POLLEN30 [hp_X]/mL
  • LOLIUM PERENNE POLLEN30 [hp_X]/mL
  • AGROSTIS GIGANTEA POLLEN30 [hp_X]/mL
  • PHLEUM PRATENSE POLLEN30 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]

Package NDCNDC-11Package
62713-989-016271309890130 mL in 1 BOTTLE, DROPPER (62713-989-01)
62713-989-026271309890259 mL in 1 BOTTLE, DROPPER (62713-989-02)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62713-989 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62713-989 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62713-989. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.